Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nose Neoplasms | 4 | 2006 | 246 | 0.830 |
Why?
|
Central Nervous System Infections | 4 | 2014 | 59 | 0.800 |
Why?
|
Ependymoma | 2 | 2017 | 319 | 0.590 |
Why?
|
Magnetic Resonance Imaging | 30 | 2022 | 35784 | 0.490 |
Why?
|
Intelligence | 1 | 2019 | 909 | 0.480 |
Why?
|
Myelitis | 1 | 2014 | 49 | 0.460 |
Why?
|
Encephalitis | 1 | 2014 | 428 | 0.360 |
Why?
|
Carotid Artery, Internal | 2 | 2003 | 430 | 0.350 |
Why?
|
Tomography, X-Ray Computed | 26 | 2019 | 20142 | 0.340 |
Why?
|
Guanine Nucleotide Exchange Factors | 3 | 2011 | 563 | 0.330 |
Why?
|
Central Nervous System Neoplasms | 1 | 2017 | 889 | 0.330 |
Why?
|
Cerebral Hemorrhage | 1 | 2019 | 2617 | 0.310 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2006 | 241 | 0.290 |
Why?
|
Frontal Sinus | 2 | 2004 | 50 | 0.290 |
Why?
|
Radiology | 2 | 2019 | 2083 | 0.280 |
Why?
|
Cysts | 3 | 2018 | 675 | 0.280 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2007 | 142 | 0.270 |
Why?
|
Spinal Cord | 1 | 2014 | 1773 | 0.260 |
Why?
|
Fasciitis, Necrotizing | 1 | 2006 | 79 | 0.260 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2372 | 0.260 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2005 | 60 | 0.250 |
Why?
|
Hemangiopericytoma | 1 | 2005 | 72 | 0.240 |
Why?
|
Solvents | 1 | 2005 | 293 | 0.230 |
Why?
|
Odontogenic Cysts | 1 | 2004 | 41 | 0.230 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2004 | 38 | 0.230 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2004 | 52 | 0.230 |
Why?
|
Meningioma | 2 | 2020 | 1203 | 0.220 |
Why?
|
Bell Palsy | 1 | 2003 | 39 | 0.220 |
Why?
|
Parotid Diseases | 1 | 2003 | 45 | 0.220 |
Why?
|
Mandibular Neoplasms | 1 | 2004 | 126 | 0.210 |
Why?
|
Tympanic Membrane | 1 | 2004 | 227 | 0.210 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2003 | 134 | 0.210 |
Why?
|
Pharynx | 1 | 2005 | 424 | 0.210 |
Why?
|
Hallucinogens | 1 | 2005 | 182 | 0.200 |
Why?
|
Appetite | 2 | 2014 | 248 | 0.200 |
Why?
|
Neck | 1 | 2006 | 703 | 0.200 |
Why?
|
Oropharynx | 1 | 2002 | 128 | 0.200 |
Why?
|
Cocaine-Related Disorders | 1 | 2005 | 453 | 0.200 |
Why?
|
Plasmacytoma | 1 | 2002 | 172 | 0.200 |
Why?
|
Brain | 12 | 2019 | 26596 | 0.200 |
Why?
|
Facial Nerve | 1 | 2003 | 273 | 0.190 |
Why?
|
Brain Neoplasms | 6 | 2022 | 8832 | 0.190 |
Why?
|
Marijuana Abuse | 1 | 2005 | 404 | 0.190 |
Why?
|
Carotid Arteries | 1 | 2005 | 932 | 0.180 |
Why?
|
Central Nervous System Diseases | 1 | 2005 | 516 | 0.180 |
Why?
|
Ear, Middle | 1 | 2003 | 335 | 0.180 |
Why?
|
Tinnitus | 1 | 2003 | 187 | 0.180 |
Why?
|
Neurofibromatosis 1 | 1 | 2005 | 554 | 0.180 |
Why?
|
Spinal Diseases | 1 | 2005 | 552 | 0.180 |
Why?
|
Meningeal Neoplasms | 2 | 2020 | 1227 | 0.180 |
Why?
|
Calcinosis | 2 | 2013 | 1415 | 0.170 |
Why?
|
Neuroradiography | 1 | 2019 | 71 | 0.170 |
Why?
|
Cauda Equina | 1 | 2019 | 45 | 0.170 |
Why?
|
Nasal Polyps | 1 | 2005 | 392 | 0.170 |
Why?
|
Chondroma | 1 | 2018 | 51 | 0.160 |
Why?
|
Hemangioma | 1 | 2003 | 723 | 0.160 |
Why?
|
Foreign Bodies | 1 | 2002 | 388 | 0.160 |
Why?
|
Arnold-Chiari Malformation | 1 | 2020 | 154 | 0.160 |
Why?
|
Granular Cell Tumor | 1 | 2018 | 48 | 0.160 |
Why?
|
Spinal Cord Compression | 1 | 2019 | 229 | 0.150 |
Why?
|
Intracranial Aneurysm | 2 | 2020 | 1206 | 0.150 |
Why?
|
Mycoses | 2 | 2014 | 383 | 0.140 |
Why?
|
Neoplasm Invasiveness | 1 | 2005 | 3584 | 0.140 |
Why?
|
Deglutition Disorders | 1 | 2002 | 610 | 0.140 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2016 | 75 | 0.130 |
Why?
|
Eating | 2 | 2014 | 1531 | 0.130 |
Why?
|
Brain Diseases | 1 | 2005 | 1541 | 0.130 |
Why?
|
rho GTP-Binding Proteins | 2 | 2011 | 281 | 0.130 |
Why?
|
Brain Stem Neoplasms | 1 | 2017 | 191 | 0.130 |
Why?
|
Intracranial Hypotension | 1 | 2015 | 40 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 1 | 2007 | 4485 | 0.120 |
Why?
|
Tobacco Smoke Pollution | 1 | 2020 | 806 | 0.120 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 709 | 0.120 |
Why?
|
Atrophy | 4 | 2013 | 1613 | 0.120 |
Why?
|
Fibrous Dysplasia, Polyostotic | 2 | 2004 | 36 | 0.120 |
Why?
|
Humans | 60 | 2022 | 746044 | 0.110 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2020 | 799 | 0.110 |
Why?
|
Radiosurgery | 2 | 2020 | 1331 | 0.110 |
Why?
|
Prion Diseases | 1 | 2014 | 97 | 0.110 |
Why?
|
Sodium Chloride | 1 | 2015 | 608 | 0.110 |
Why?
|
Cerebral Arterial Diseases | 1 | 2013 | 81 | 0.110 |
Why?
|
Cerebral Angiography | 3 | 2013 | 1241 | 0.100 |
Why?
|
Spermatozoa | 1 | 2016 | 634 | 0.100 |
Why?
|
rhoA GTP-Binding Protein | 2 | 2011 | 236 | 0.100 |
Why?
|
Forecasting | 2 | 2019 | 2905 | 0.100 |
Why?
|
Hydrocephalus | 1 | 2018 | 752 | 0.100 |
Why?
|
Artifacts | 1 | 2019 | 1873 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2014 | 663 | 0.090 |
Why?
|
Glycemic Index | 1 | 2013 | 391 | 0.090 |
Why?
|
Follicular Phase | 1 | 2011 | 143 | 0.090 |
Why?
|
Gait Disorders, Neurologic | 2 | 2013 | 233 | 0.090 |
Why?
|
Clinical Competence | 2 | 2019 | 4670 | 0.090 |
Why?
|
Opioid-Related Disorders | 1 | 2005 | 2089 | 0.090 |
Why?
|
Defibrillators, Implantable | 1 | 2019 | 1435 | 0.090 |
Why?
|
Female | 31 | 2020 | 382109 | 0.090 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1306 | 0.090 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1501 | 0.090 |
Why?
|
Embolism | 1 | 2013 | 405 | 0.090 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2853 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2006 | 6298 | 0.080 |
Why?
|
Middle Aged | 21 | 2020 | 214412 | 0.080 |
Why?
|
Substance-Related Disorders | 1 | 2005 | 4294 | 0.080 |
Why?
|
Cerebral Arteries | 1 | 2011 | 489 | 0.080 |
Why?
|
Virus Diseases | 1 | 2014 | 722 | 0.080 |
Why?
|
Corpus Callosum | 1 | 2013 | 729 | 0.080 |
Why?
|
Gadolinium | 2 | 2022 | 945 | 0.080 |
Why?
|
Brain Edema | 1 | 2012 | 594 | 0.080 |
Why?
|
Protein Structure, Secondary | 2 | 2011 | 1238 | 0.080 |
Why?
|
Male | 27 | 2020 | 351093 | 0.080 |
Why?
|
Gait | 1 | 2013 | 799 | 0.070 |
Why?
|
Glioblastoma | 1 | 2022 | 3453 | 0.070 |
Why?
|
Sensitivity and Specificity | 5 | 2019 | 14537 | 0.070 |
Why?
|
Pain | 1 | 2002 | 4980 | 0.070 |
Why?
|
Tissue Plasminogen Activator | 1 | 2013 | 1153 | 0.070 |
Why?
|
Enzyme Inhibitors | 2 | 2016 | 3695 | 0.070 |
Why?
|
Reward | 1 | 2013 | 932 | 0.070 |
Why?
|
Leptin | 1 | 2014 | 1579 | 0.070 |
Why?
|
Biochemistry | 1 | 2007 | 114 | 0.070 |
Why?
|
Protein Structure, Tertiary | 3 | 2011 | 3784 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2020 | 2891 | 0.070 |
Why?
|
Protein Isoforms | 1 | 2011 | 1688 | 0.070 |
Why?
|
Biophysics | 1 | 2007 | 382 | 0.070 |
Why?
|
Internship and Residency | 2 | 2019 | 5762 | 0.070 |
Why?
|
Alcohol-Induced Disorders, Nervous System | 1 | 2005 | 12 | 0.070 |
Why?
|
Toluene | 1 | 2005 | 32 | 0.060 |
Why?
|
Dimerization | 1 | 2007 | 886 | 0.060 |
Why?
|
Follow-Up Studies | 6 | 2022 | 38752 | 0.060 |
Why?
|
Avitaminosis | 1 | 2005 | 35 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2019 | 15341 | 0.060 |
Why?
|
Adult | 13 | 2020 | 214958 | 0.060 |
Why?
|
Narcotics | 1 | 2007 | 336 | 0.060 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2004 | 25 | 0.060 |
Why?
|
Fasting | 1 | 2011 | 1575 | 0.060 |
Why?
|
Methadone | 1 | 2007 | 310 | 0.060 |
Why?
|
raf Kinases | 1 | 2005 | 119 | 0.060 |
Why?
|
Dura Mater | 2 | 2018 | 286 | 0.060 |
Why?
|
Fibrous Dysplasia, Monostotic | 1 | 2004 | 8 | 0.060 |
Why?
|
Epistaxis | 1 | 2005 | 110 | 0.060 |
Why?
|
Postural Balance | 1 | 2009 | 607 | 0.060 |
Why?
|
Petrous Bone | 1 | 2004 | 84 | 0.060 |
Why?
|
Mucocele | 1 | 2004 | 51 | 0.060 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2011 | 1020 | 0.060 |
Why?
|
Debridement | 1 | 2006 | 494 | 0.060 |
Why?
|
Azacitidine | 1 | 2005 | 333 | 0.060 |
Why?
|
Brain Abscess | 1 | 2004 | 117 | 0.060 |
Why?
|
Empty Sella Syndrome | 1 | 2002 | 14 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2007 | 2766 | 0.050 |
Why?
|
Mastoiditis | 1 | 2002 | 36 | 0.050 |
Why?
|
Visual Perception | 1 | 2011 | 1374 | 0.050 |
Why?
|
Radiography | 2 | 2005 | 6939 | 0.050 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2004 | 179 | 0.050 |
Why?
|
Parotid Neoplasms | 1 | 2004 | 155 | 0.050 |
Why?
|
Sampling Studies | 1 | 2004 | 617 | 0.050 |
Why?
|
Pyrroles | 1 | 2009 | 1129 | 0.050 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2002 | 86 | 0.050 |
Why?
|
Sjogren's Syndrome | 1 | 2004 | 234 | 0.050 |
Why?
|
Administration, Inhalation | 1 | 2005 | 1140 | 0.050 |
Why?
|
Nasal Mucosa | 1 | 2005 | 410 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3306 | 0.050 |
Why?
|
Encephalocele | 1 | 2002 | 134 | 0.050 |
Why?
|
Pharyngeal Diseases | 1 | 2002 | 135 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2014 | 12839 | 0.050 |
Why?
|
Neck Injuries | 1 | 2002 | 149 | 0.050 |
Why?
|
Fistula | 1 | 2002 | 213 | 0.050 |
Why?
|
Protein Binding | 3 | 2011 | 9278 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1394 | 0.050 |
Why?
|
Indoles | 1 | 2009 | 1804 | 0.050 |
Why?
|
Bone Diseases | 1 | 2004 | 413 | 0.050 |
Why?
|
Nasal Cavity | 1 | 2002 | 304 | 0.040 |
Why?
|
Risk Assessment | 4 | 2005 | 23453 | 0.040 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2002 | 313 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2020 | 5092 | 0.040 |
Why?
|
Injury Severity Score | 1 | 2002 | 1018 | 0.040 |
Why?
|
Radiographic Image Enhancement | 1 | 2004 | 868 | 0.040 |
Why?
|
Brain Mapping | 3 | 2013 | 6594 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6213 | 0.040 |
Why?
|
Intubation, Intratracheal | 1 | 2006 | 1355 | 0.040 |
Why?
|
Phantom Limb | 1 | 2000 | 94 | 0.040 |
Why?
|
Cerebral Aqueduct | 1 | 2018 | 39 | 0.040 |
Why?
|
Craniotomy | 2 | 2020 | 737 | 0.040 |
Why?
|
Cysticercosis | 1 | 1997 | 34 | 0.040 |
Why?
|
Rhinitis | 1 | 2005 | 738 | 0.040 |
Why?
|
Aged | 9 | 2020 | 164236 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2002 | 1634 | 0.040 |
Why?
|
HIV Infections | 1 | 2003 | 16936 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2009 | 2254 | 0.030 |
Why?
|
Syndrome | 1 | 2002 | 3245 | 0.030 |
Why?
|
Sinusitis | 1 | 2005 | 977 | 0.030 |
Why?
|
Fatal Outcome | 2 | 2013 | 1825 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 13494 | 0.030 |
Why?
|
Injections, Spinal | 1 | 2015 | 302 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2020 | 591 | 0.030 |
Why?
|
Blotting, Western | 3 | 2011 | 5048 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 78297 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2855 | 0.030 |
Why?
|
Sperm Motility | 1 | 2016 | 267 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 17675 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2019 | 905 | 0.030 |
Why?
|
Adolescent | 4 | 2014 | 86202 | 0.030 |
Why?
|
Hemangioma, Cavernous | 1 | 1994 | 108 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2020 | 2893 | 0.030 |
Why?
|
Signal Transduction | 2 | 2007 | 23112 | 0.030 |
Why?
|
Pregnancy | 3 | 2020 | 29294 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4248 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2020 | 915 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2005 | 3657 | 0.030 |
Why?
|
Contrast Media | 2 | 2019 | 5253 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2019 | 1178 | 0.030 |
Why?
|
Ultrasonography | 1 | 2005 | 5899 | 0.030 |
Why?
|
Glycolysis | 1 | 2016 | 814 | 0.020 |
Why?
|
Triiodobenzoic Acids | 1 | 2011 | 122 | 0.020 |
Why?
|
Middle Cerebral Artery | 1 | 2013 | 264 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2014 | 63661 | 0.020 |
Why?
|
Hunger | 1 | 2013 | 202 | 0.020 |
Why?
|
Postprandial Period | 1 | 2013 | 304 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29068 | 0.020 |
Why?
|
Deep Brain Stimulation | 1 | 2019 | 787 | 0.020 |
Why?
|
Isoenzymes | 1 | 2016 | 1693 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2016 | 1970 | 0.020 |
Why?
|
DNA Methylation | 1 | 2005 | 4258 | 0.020 |
Why?
|
Obesity | 1 | 2013 | 12670 | 0.020 |
Why?
|
Circular Dichroism | 1 | 2011 | 347 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2005 | 1993 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2011 | 320 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2011 | 640 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2005 | 11064 | 0.020 |
Why?
|
Food | 1 | 2014 | 769 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2016 | 1980 | 0.020 |
Why?
|
Hypothalamus | 1 | 2014 | 992 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13538 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1601 | 0.020 |
Why?
|
Hormone Replacement Therapy | 1 | 2014 | 742 | 0.020 |
Why?
|
Apoptosis | 1 | 2005 | 9421 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57557 | 0.020 |
Why?
|
Developing Countries | 1 | 2001 | 2803 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2019 | 1988 | 0.020 |
Why?
|
Software | 1 | 2022 | 4399 | 0.020 |
Why?
|
Stroke | 1 | 2011 | 9693 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2014 | 1973 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2006 | 7222 | 0.020 |
Why?
|
Sensation Disorders | 1 | 2009 | 156 | 0.020 |
Why?
|
Hepatitis, Autoimmune | 1 | 2009 | 166 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12632 | 0.020 |
Why?
|
Incidence | 1 | 2004 | 20812 | 0.020 |
Why?
|
Agar | 1 | 2005 | 53 | 0.020 |
Why?
|
Butadienes | 1 | 2005 | 106 | 0.020 |
Why?
|
Methanol | 1 | 2005 | 88 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2009 | 848 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19804 | 0.010 |
Why?
|
Tomography, X-Ray | 1 | 2004 | 60 | 0.010 |
Why?
|
Cell Line | 2 | 2011 | 15631 | 0.010 |
Why?
|
Estradiol | 1 | 2011 | 1941 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2005 | 671 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2005 | 1547 | 0.010 |
Why?
|
Parotid Gland | 1 | 2004 | 167 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21673 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7271 | 0.010 |
Why?
|
Diffusion Tensor Imaging | 1 | 2013 | 2348 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2003 | 530 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2014 | 15537 | 0.010 |
Why?
|
Flavonoids | 1 | 2005 | 441 | 0.010 |
Why?
|
3T3 Cells | 1 | 2003 | 1083 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9520 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2003 | 683 | 0.010 |
Why?
|
Ovary | 1 | 2005 | 961 | 0.010 |
Why?
|
Nitriles | 1 | 2005 | 946 | 0.010 |
Why?
|
Amputation Stumps | 1 | 2000 | 38 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1135 | 0.010 |
Why?
|
Health Planning | 1 | 2001 | 235 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2009 | 2416 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12018 | 0.010 |
Why?
|
Ethanol | 1 | 2005 | 1316 | 0.010 |
Why?
|
Mexico | 1 | 2001 | 728 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4010 | 0.010 |
Why?
|
Physical Stimulation | 1 | 2000 | 517 | 0.010 |
Why?
|
Cerebral Ventriculography | 1 | 1997 | 44 | 0.010 |
Why?
|
Mice | 3 | 2016 | 80087 | 0.010 |
Why?
|
Spinal Canal | 1 | 1997 | 39 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 2905 | 0.010 |
Why?
|
Subarachnoid Space | 1 | 1997 | 79 | 0.010 |
Why?
|
Young Adult | 2 | 2014 | 57106 | 0.010 |
Why?
|
Equipment Design | 1 | 2005 | 3509 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2005 | 2469 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 3601 | 0.010 |
Why?
|
HIV-1 | 1 | 2014 | 6870 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4114 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3782 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6058 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2005 | 3346 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2005 | 2865 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2005 | 2800 | 0.010 |
Why?
|
RNA | 1 | 2005 | 2693 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 1997 | 540 | 0.010 |
Why?
|
Fibroblasts | 1 | 2005 | 4036 | 0.010 |
Why?
|
Leg | 1 | 2000 | 1086 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2003 | 4119 | 0.010 |
Why?
|
Alleles | 1 | 2005 | 6831 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72416 | 0.010 |
Why?
|
Cell Membrane | 1 | 2003 | 3687 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2001 | 1390 | 0.010 |
Why?
|
Animals | 3 | 2016 | 166331 | 0.010 |
Why?
|
Models, Molecular | 1 | 2003 | 5379 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9170 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 5607 | 0.010 |
Why?
|
Occipital Lobe | 1 | 1994 | 373 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 25177 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2000 | 1420 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12741 | 0.010 |
Why?
|
Child | 1 | 2018 | 78456 | 0.010 |
Why?
|
Rats | 1 | 2005 | 23680 | 0.010 |
Why?
|
Prospective Studies | 1 | 2013 | 53218 | 0.000 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16657 | 0.000 |
Why?
|
Infant | 1 | 2007 | 35444 | 0.000 |
Why?
|
Time Factors | 1 | 2003 | 39587 | 0.000 |
Why?
|
Mutation | 1 | 2005 | 29614 | 0.000 |
Why?
|